JNJ


Johnson & Johnson’s Janssen Receives FDA Approval For PONVORY Therapy; Street Sees Over 19% Upside

Janssen, a Johnson & Johnson (JNJ) company, announced that the US Food and Drug Administration (FDA) has approved its PONVORY (ponesimod) therapy as …

Johnson & Johnson’s Single-Dose COVID-19 Vaccine Granted Emergency Use Listing By WHO

Johnson & Johnson’s single-dose COVID-19 vaccine, which was developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), has been issued an …

J&J’s Single-Dose COVID-19 Vaccine Cleared For Emergency Use In US

Johnson & Johnson’s single-dose COVID-19 vaccine has been authorized for emergency use by the US Food and Drug Administration (FDA) for the treatment …

J&J Files For FDA Approval Of COVID-19 Vaccine; Street is Bullish

Johnson & Johnson has submitted an application to the US Food and Drug Administration (FDA) for emergency use authorization (EUA) of its investigational …

Johnson & Johnson’s Single-Dose Vaccine Could Be Approved by Next Month – Report

Scientists and government sources claimed today that Johnson & Johnson’s single-jab COVID-19 vaccine could be given emergency use authorization as early as next …

J&J Strikes Covid-19 Vaccine Manufacturing Deal With Aspen

Johnson & Johnson has struck a preliminary agreement with Aspen Pharmacare Holdings to manufacture its Covid-19 vaccine candidate Ad26.COV2-S at a factory in …

American Express Hit With 40% Profit Slump; Shares Fall 3.6%

Shares in American Express depreciated 3.6% on Friday after the credit card issuer posted a 40% decline in quarterly profit and forecast that …

J&J Offers Up To $5B In US Opioid Addiction Settlement

Johnson & Johnson said it will contribute up to an additional $1 billion for a potential settlement agreement to resolve US opioid lawsuits …

J&J Halts Covid-19 Vaccine Trial Due To ‘Unexplained Illness’

Johnson & Johnson (JNJ) has halted its late-stage Covid-19 vaccine trial after a study participant fell ill, news provider STAT has reported. The …

J&J’s Tremfya Study Shows Improvement In Crohn’s Disease Patients

Johnson & Johnson said Monday that its Tremfya drug induced clinical and endoscopic improvements in adult patients with moderately to severely active Crohn’s …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts